Literature DB >> 11394647

Hydrophilic bile salts enhance differential distribution of sphingomyelin and phosphatidylcholine between micellar and vesicular phases: potential implications for their effects in vivo.

A Moschetta1, G P vanBerge-Henegouwen, P Portincasa, W L Renooij, A K Groen, K J van Erpecum.   

Abstract

BACKGROUND/AIMS: The hepatocyte canalicular membrane outer leaflet contains both phosphatidylcholine (PC) and sphingomyelin (SM). Normally, PC is the exclusive phospholipid in bile. We examined effects of bile salt hydrophobicity on cytotoxicity and on differential SM and PC distribution between detergent-resistant aggregated vesicles (model for detergent-resistant canalicular membrane) and mixed micelles or small unilamellar vesicles (representing lipid phases in bile).
METHODS: Aggregated vesicles were obtained by ultracentrifugation of cholesterol-supersaturated model systems containing SM, PC and various bile salts, micelles by ultrafiltration and unilamellar vesicles by dialysis of the supernatant. Erythrocyte hemolysis and lactate dehydrogenase release from CaCo-2 cells upon incubation with various micelles were quantified.
RESULTS: Preferential SM distribution and lipid solubilization in aggregated vesicles increased in rank order taurodeoxycholate < taurocholate < tauroursodeoxycholate < taurohyodeoxycholate, with reciprocal PC enrichment in micelles and small unilamellar vesicles. Including small amounts of PC within taurohyodeoxycholate micelles increased cytotoxicity with more erythrocyte hemolysis and LDH release from CaCo-2 cells upon incubation, but decreased cytotoxicity in case of tauroursodeoxycholate micelles.
CONCLUSIONS: Hydrophilic but not hydrophobic bile salts preserve integrity of pathophysiologically relevant phosphatidylcholine plus sphingomyelin-containing bilayers. Enhanced biliary phospholipid secretion during taurohyodeoxycholate but not during tauroursodeoxycholate therapy (Hepatology 25 (1997) 1306) may relate to different interactions of these bile salts with phospholipids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11394647     DOI: 10.1016/s0168-8278(00)00046-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Role of nucleation of bile liquid crystal in gallstone formation.

Authors:  Hai-Ming Yang; Jie Wu; Jin-Yi Li; Lin Gu; Min-Fei Zhou
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 2.  Primary sclerosing cholangitis: updates in diagnosis and therapy.

Authors:  Piero Portincasa; Michele Vacca; Antonio Moschetta; Michele Petruzzelli; Giuseppe Palasciano; Karel J van Erpecum; Gerard P van Berge-Henegouwen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

3.  Indomethacin enhances bile salt detergent activity: relevance for NSAIDs-induced gastrointestinal mucosal injury.

Authors:  M Petruzzelli; A Moschetta; W Renooij; M B M de Smet; G Palasciano; P Portincasa; K J van Erpecum
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

4.  Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output.

Authors:  Anna Baghdasaryan; Thierry Claudel; Judith Gumhold; Dagmar Silbert; Luciano Adorini; Aldo Roda; Stefania Vecchiotti; Frank J Gonzalez; Kristina Schoonjans; Mario Strazzabosco; Peter Fickert; Michael Trauner
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

Review 5.  Deciphering the nuclear bile acid receptor FXR paradigm.

Authors:  Salvatore Modica; Raffaella M Gadaleta; Antonio Moschetta
Journal:  Nucl Recept Signal       Date:  2010-11-19

6.  Involvement of SIK3 in glucose and lipid homeostasis in mice.

Authors:  Tatsuya Uebi; Yumi Itoh; Osamu Hatano; Ayako Kumagai; Masato Sanosaka; Tsutomu Sasaki; Satoru Sasagawa; Junko Doi; Keita Tatsumi; Kuniko Mitamura; Eiichi Morii; Katsuyuki Aozasa; Tomohiro Kawamura; Meinoshin Okumura; Jun Nakae; Hajime Takikawa; Toshio Fukusato; Minako Koura; Mayumi Nish; Anders Hamsten; Angela Silveira; Alejandro M Bertorello; Kazuo Kitagawa; Yasuo Nagaoka; Hidehisa Kawahara; Takeshi Tomonaga; Tetsuji Naka; Shigeo Ikegawa; Noriyuki Tsumaki; Junichiro Matsuda; Hiroshi Takemori
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

7.  Cholesterol attenuates cytoprotective effects of phosphatidylcholine against bile salts.

Authors:  Yoshito Ikeda; Shin-Ya Morita; Tomohiro Terada
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.